Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
10.02
-0.32 (-3.09%)
At close: Nov 10, 2026, 4:00 PM EST
9.55
-0.47 (-4.69%)
Pre-market: Nov 11, 2026, 8:30 AM EST
Biodesix Market Cap
Biodesix has a market cap or net worth of $111.11 million as of November 10, 2026. It is the 24,293rd most valuable company in the world and the 3,985th biggest in the United States. Its market cap has increased by 62.39% in one year.
Market Cap
111.11M
Enterprise Value
155.14M
1-Year Change
62.39%
Global Rank
Country Rank
#3,985 United States
Category
ChartMarket Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $111.11M, a decrease of -66.96%. That is a compound annual growth rate of -16.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 94.58M | 74.84% |
| Dec 31, 2025 | 54.10M | -75.69% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OPKO Health | 1.27B |
| Freenome | 1.14B |
| Castle Biosciences | 1.06B |
| Fulgent Genetics | 730.60M |
| Myriad Genetics | 550.59M |
| Exagen | 172.00M |
| Burning Rock Biotech | 130.67M |
| Insight Molecular Diagnostics | 81.81M |